A testimonial
This is my second order. After 10 years of suffering, this product cleared my problem up within 48 hours. I have spent a fortune on both prescription and non-prescription medicines, and have always had a lingering naseau and stomach pains. I have been diagnosed with IBS, H Pylori, and other gastric problems. Mastica has given me genuine relief.
Joel S. Covington, LA
Mastica, the resinous gum of a species of Greek pistachio tree, Pistacia lentiscus, has been used in Greece for hundreds of years as a remedy for a broad range of gastro-intestinal disorders. It has been found to be an effective alternative to pharmaceuticals in the treatment of gastrititis, gastro-esophegeal reflux disease (GERD) and many types of intestinal inflammation. It is a safe and effective alternative to antibiotics in the treatment of stomach and duodenal ulcers and the clearance of the bacteria so frequently the cause of these conditions, Helicobacter pylori (H. pylori). Unlike antibiotics, Mastica does not eradicate the populations of friendly bacteria in the intestines, so crucial to health and well-being.
Recommended usage:
2 capsules, 2 times daily, between meals. Chronic cases should be treated for a minimum of four weeks. Mastica is well tolerated and has not been known to cause side effects. It can be safely used by individuals on pharmaceutical medications.
Article–Mastic Gum Kills Helicobacter pylori
Source: New England Journal of Medicine
Farhad U. Huwez, M.R.C.P., Ph.D.
Barnet General Hospital, Barnet, Herts EN5 3DJ, United Kingdom
Debbie Thirlwell, B.Sc., Alan Cockayne, Ph.D.
Dlawer A.A. Ala’Aldeen, Ph.D., M.R.C.Path.
University Hospital, Nottingham NG7 2UH, United Kingdom
Even low doses of mastic gum — 1 g per day for two weeks — can cure peptic ulcers very rapidly, but the mechanism responsible has not been clear. We have found that mastic is active against Helicobacter pylori, which could explain its therapeutic effect in patients with peptic ulcers.
Mastic is a resinous exudate obtained from the stem and the main leaves of Pistacia lentiscus. It is used as a food ingredient in the Mediterranean region. Clinically, mastic has been effective in the treatment of benign gastric ulcers (1) and duodenal ulcers. (2) In rats, mastic showed cytoprotective and mild antisecretory properties. (3) We assessed the antibacterial properties of mastic against H. pylori.
The H. pylori strains NCTC 11637 (a standard reference strain) and six fresh clinical isolates (three were sensitive and three were resistant to metronidazole) were maintained by passage on 7 percent horse chocolate blood agar or in IsoSensitest broth (with 5 percent fetal-calf serum) at 37蚓 in a microaerobic atmosphere (6 percent oxygen and 5 percent carbon dioxide in nitrogen).
Mastic was prepared as a stock solution in ethanol at a concentration of 50 mg per milliliter and diluted in the broth culture (containing 107 cells of H. pylori per milliliter) for a final concentration ranging from 0.0075 to 1.0 mg per milliliter. Ethanol was added to control cultures at appropriate concentrations. The cultures were incubated, 10-痞 aliquots were obtained and seeded on agar plates at various times for up to 48 hours, and the minimal bactericidal concentrations (the minimal concentration of drug required to kill 99.9 percent of the organisms in the medium after overnight incubation) were determined.
Mastic killed the H. pylori NCTC 11637 strain and the six clinical isolates (reduction in the viable count by a factor of 1000) irrespective of the organism’s level of susceptibility to nitroimidazoles. The minimal bactericidal concentration at 24 hours for all strains that were studied was 0.06 mg of the crude mastic per milliliter. At lower concentrations, bacterial growth was still significantly inhibited, with a clear postantibiotic effect even at the lowest concentration used, 0.0075 mg per milliliter. Mastic induced clear ultrastructural changes in the organism, as demonstrated by transmission electron microscopy (data not shown).
These results suggest that mastic has definite antibacterial activity against H. pylori. This activity may at least partly explain the anti-peptic-ulcer properties of mastic. (1,2) Examination of the anti-H. pylori effect of the various constituents of mastic, which have been recently identified, (4) may pinpoint the active ingredient. Mastic is cheap and widely available in Third World countries; therefore, our data should have important implications for the management of peptic ulcers in developing countries.
References:
1. Huwez FU, Al-Habbal MJ. Mastic in treatment of benign gastric ulcers. Gastroenterol Japon 1986;21:273-4.
2. Al-Habbal MJ, Al-Habbal Z, Huwez FU. A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. J Clin Exp Pharm Physiol 1984;11:541-4.
3. Al-Said MS, Ageel AM, Parmar NS, Tariq M. Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J Ethnopharmacol 1986;15:271-8.
4. Papageorgiou VP, Bakola-Christianopoulou MN, Apazidou KK, Psarros EE. Gas chromatographic-mass spectroscopic analysis of the acidic triterpenic fraction of mastic gum. J Chromatogr 1997;769:263-73.
